Cost-effectiveness of introducing a rotavirus vaccine in developing countries: The case of Mexico

by Gutierrez Juan-Pablo, Bertozzi Stefano M, Valencia-Mendoza Atanacio, Itzler Robbin
Published 2008-07-01

Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV...

by Van Damme Pierre, Gothefors Leif, Matson David O, Koch Gary, Itzler Robbin, DiNubile Mark J, Heaton Penny M
Published 2010-06-01